Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

by Asanuma Hiroko, Hirohashi Yoshihiko, Yagihashi Atsuhito, Toyota Nobuhiko, Torigoe Toshihiko, Kimura Yasutoshi, Yamaguchi Koji, Furuhata Tomohisa, Hata Fumitake, Katsuramaki Tadashi, Ohmura Tosei, Iwayama Yuji, Tsuruma Tetsuhiro, Shimozawa Kumiko, Okazaki Minoru, Mizushima Yasuhiro, Nomura Naohiro, Sato Noriyuki, Hirata Koichi
Published 2008-05-01